On the other hand, in a previous study, SATB1 was considered an oncogene in CD30+ cutaneous T-cell lymphomas because its activity was directed towards silencing p21 [14]. This evidence concerns the gene SATB1 and primary cutaneous T-cell non-Hodgkin lymphoma.